HighTower Advisors’s Zai Lab ZLAB Stock Holding History

HighTower Advisors’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,933	Closed	-$203K	–	3512
2021 Q3	$203K	Buy	+1,933	New	+$278K	﹤0.01%	2703

Other funds holding ZLAB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors's ZLAB Position: Q4 2021 in Review

HighTower Advisors sold out of Zai Lab (ZLAB) in Q4 2021, closing a stake of 1,933 shares — an estimated $203K sold.

HighTower Advisors first reported a position in ZLAB in Q3 2021 and held it in 1 quarter. The position peaked at $203K in Q3 2021. 206 funds tracked by Wall St. Rank hold ZLAB as of Q4 2021.

HighTower Advisors reported no remaining Zai Lab position as of Q4 2021 after selling out during the quarter.
HighTower Advisors sold 1,933 Zai Lab shares in Q4 2021, an estimated $203K.
HighTower Advisors first reported a position in Zai Lab in Q3 2021 and held it in 1 quarter.
HighTower Advisors's Zai Lab position peaked at $203K in Q3 2021.
206 funds tracked by Wall St. Rank held Zai Lab as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.